Compare VHI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VHI | CTKB |
|---|---|---|
| Founded | 1932 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 505.0M | 541.1M |
| IPO Year | 1994 | 2021 |
| Metric | VHI | CTKB |
|---|---|---|
| Price | $15.51 | $5.74 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $5.63 |
| AVG Volume (30 Days) | 10.2K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $2,077,000,000.00 | $193,015,000.00 |
| Revenue This Year | $33.32 | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | $18.81 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $11.44 | $3.31 |
| 52 Week High | $19.19 | $6.18 |
| Indicator | VHI | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 36.88 | 71.54 |
| Support Level | $15.51 | $4.17 |
| Resistance Level | $15.95 | $6.04 |
| Average True Range (ATR) | 0.79 | 0.25 |
| MACD | -0.31 | 0.08 |
| Stochastic Oscillator | 10.88 | 86.81 |
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.